Healthcare
Hyperfine, Inc.(HYPR)
Live Price
Offline$1.60
+15.11% today
1Y Change
+104.74%
Window
Jun 25, 2025 โ Jun 23, 2026
- Market Cap
- $140.00M
- Revenue Growth
- +5.2%
- EPS Growth
- +23.2%
- Dividend Yield
- 0.0%
Coverage: 249 bars ยท Jun 25, 2025 โ Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Hyperfine, Inc. (HYPR) is a Healthcare stock with a market cap of $140.00M and listed on NASDAQ. The stock last traded around $1.60 and up 104.7% across the available one-year price window (Jun 25, 2025 โ Jun 23, 2026). Baseline metrics include revenue growth of +5.2%, EPS growth of +23.2%, a dividend yield of 0.0%. What stands out right now is revenue +5.2%, EPS +23.2%, free cash flow +25.6% with operating margin -273.4% and ROIC -84.7%. Valuation already assumes a fairly strong business story at price/sales 10.0. Stock Foundry combines HYPR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+5.2% vs +7.6% peer median
Operating Margin
Below sector median
-273.4% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 12, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +5.2% and EPS at +23.2%, with operating margin around -273.4%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -9.6% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 12, 2026 | โ | -8.1% | -18.5% | -19.1% |
2026 Mar 18, 2026 | +0.0% | -4.7% | -7.9% | +4.7% |
2025 Nov 13, 2025 | -10.0% | +9.5% | -2.4% | -5.1% |
Benchmark Edge
HYPR vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
HYPR
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
HYPR Max Drawdown
-59.09%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for HYPR and SPY.
Company Overview
Hyperfine, Inc.
NASDAQ Global Market
Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.
- Leadership
- Maria Degois-Sainz
- IPO Date
- Jan 28, 2021
- Employees
- 111
- Street Address
- 351 New Whitfield Street
- Mailing
- Guilford, CT, 06437
- Region
- Guilford, CT, US
- Reporting Currency
- USD
- Investor Line
- 203-458-7100
- Last Updated
- Apr 30, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 10.0
- Price/Book
- 3.8
Growth
- Revenue
- +5.2%
- EPS
- +23.2%
- Free Cash Flow
- +25.6%
Profitability
- Gross Margin
- 49.8%
- Operating Margin
- -273.4%
- Net Margin
- -262.3%
- ROE
- -97.4%
- ROIC
- -84.7%
Balance Sheet
- Debt/Equity
- 0.01
- Current Ratio
- 4.34
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.